Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Recent studies have suggested a bacterial role in the development of autoimmune disorders including type 1 diabetes (T1D). Over 30 billion nucleotide bases of Illumina shotgun metagenomic data were analyzed from stool samples collected from four pairs of matched T1D case-control subjects collected at the time of the development of T1D associated autoimmunity (i.e., autoantibodies). From these, approximately one million open reading frames were predicted and compared to the SEED protein database. Of the 3,849 functions identified in these samples, 144 and 797 were statistically more prevalent in cases and controls, respectively. Genes involved in carbohydrate metabolism, adhesions, motility, phages, prophages, sulfur metabolism, and stress responses were more abundant in cases while genes with roles in DNA and protein metabolism, aerobic respiration, and amino acid synthesis were more common in controls. These data suggest that increased adhesion and flagella synthesis in autoimmune subjects may be involved in triggering a T1D associated autoimmune response. Extensive differences in metabolic potential indicate that autoimmune subjects have a functionally aberrant microbiome. Mining 16S rRNA data from these datasets showed a higher proportion of butyrate-producing and mucin-degrading bacteria in controls compared to cases, while those bacteria that produce short chain fatty acids other than butyrate were higher in cases. Thus, a key rate-limiting step in butyrate synthesis is more abundant in controls. These data suggest that a consortium of lactate- and butyrate-producing bacteria in a healthy gut induce a sufficient amount of mucin synthesis to maintain gut integrity. In contrast, non-butyrate-producing lactate-utilizing bacteria prevent optimal mucin synthesis, as identified in autoimmune subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent findings linked an aberrant microbiome, which is generally represented by diminished diversity, including fewer butyrate-producing (butyrate was shown to trigger mucin production and hence gut integrity) and mucin-degrading bacteria,241 to the development of autoimmunity in T1DM.242”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [241]
The cited source says what the claim attributes to it.
In the citing paper
“The authors further indicate that a decrease in Prevotella might be related with a reduction in mucin synthesis which is associated with increased gut permeability (Brown et al., 2011;Forsyth et al., 2011) intensifying the translocation of bacterial antigens.”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Abnormalities of GI motility might increase the occurrence of SIBO which is highly prevalent in PD patients (Brown et al., 2011;Sánchez-Ferro et al., 2015), even in recently diagnosed PD patients (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Experimental — accuracy not yet measuredIn the citing paper
“As mentioned before, SIBO is highly prevalent in PD (Andrews et al., 2009;Brown et al., 2011) and PD patients that tested positive for SIBO are predisposed to worse motordysfunction (Tan et al., 2014).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Brown et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
McCullagh, P., & Nelder, J. A. (1989) · doi:10.1007/978-1-4899-3242-6 · Cited by 16,836
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 3×
“At the phylum level and at p-values less than 0.001, Actinobacteria, Bacteroidetes, and Proteobacteria were higher in cases while Firmicutes, Fusobacteria, Tenericutes, and Verrucomicrobia were higher in controls.”
BackgroundInfluentialGeneralized, Linear, and Mixed Models
McCulloch, C. E., & Searle, S. R. (2000) · Wiley Series in Probability and Statistics · doi:10.1002/0471722073 · Cited by 2,994
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundThe Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
Bach, J.-F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020100 · Cited by 2,687
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179 · cited 1×
“Butyrate is known as an anti-inflammatory short chain fatty acid that contributes to colon health [31–33].”
BackgroundPeng, L., Li, Z.-R., Green, R. S., Holzmanr, I. R., & Lin, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.104638 · Cited by 2,130
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium
Derrien, M., Vaughan, E. E., Plugge, C. M., & de Vos, W. M. (2004) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijs.0.02873-0 · Cited by 2,094 · cited 2×
“Perspective signatures of increased mucin synthesis in the gut may be the presence of Prevotella and Akkermansia as both genera are known to degrade mucin [30,39].”
BackgroundInnate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921 · cited 2×
“Intestinal microbes and the innate immune system also interact to affect the development of diabetes in NOD mice [15].”
Background
Cited by
Items 601–700 of 777
Zhang, Y., Feng, D., Zeng, Y., Zhang, H., Du, X., Fu, Y., Wang, X., Lian, D., Wang, R., Xiao, H., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.833972 · Cited by 8
Taneja, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00026-9 · Cited by 7
Devi, M. B., Sarma, H. K., Mukherjee, A. K., & Khan, M. R. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10087-1 · Cited by 5
Abuqwider, J., Salamone, D., Scidà, G., Corrado, A., Costabile, G., Luongo, D., Annuzzi, G., Rivellese, A. A., & Bozzetto, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-096994 · Cited by 4
Acetate Administration Ameliorates Streptozotocin‐Induced Hyperglycemia and Adipose Tissue Loss
Zhang, C., Wang, Z., Luo, L., Liu, X., Jia, Z., & Zhang, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202500776r · Cited by 6
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-1245-5623 · Cited by 4
“Die aktuelle Studienlage legt außerdem nahe, dass eine Assoziation zwischen verringerter Produktion an kurzkettigen Fettsäuren, insbesondere Butyrat, durch das Mikrobiom und einem erhöhten Risiko, an Typ-1-Diabetes zu erkranken, besteht [118, 125, 127].”
BackgroundBoumenir, M., Hornick, J., Taminiau, B., Daube, G., Brotcorne, F., Iguer‐Ouada, M., & Moula, N. (2022) · Biology · doi:10.3390/biology11020187 · Cited by 5
“Furthermore, diabetes [9], Alzheimer’s disease [10] and Crohn’s disease [11] have all been linked to the GI microbiota dysfunction.”
BackgroundProbiotics in the Management of Diabetes
Kumar, A., Pramanik, J., Goyal, N., Prajapati, B. G., & Chauhan, D. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.110338 · Cited by 4
Kennedy, E. C., Ross, F. C., O'Shea, C., Lavelle, A., Ross, R. P., Dempsey, E. M., Stanton, C., & Hawkes, C. P. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-089206 · Cited by 4
“Lower numbers of specific species of Clostridium (clusters IV and XIVa), 10 31 Prevotella 13 and Akkermansia 13 have also been identified in children with new-onset T1D.”
A network analysis of methane and feed conversion genes in the rumen microbial community
Browne, F., Wang, H., Zheng, H., Roehe, R., Dewhurst, R. J., & Walsh, P. (2016) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2016.7822741 · Cited by 4
“A number of metagenomic studies have investigated rumen microbial populations [13][14][15].”
BackgroundGregorczyk‐Maga, I., Kania, M., Dąbrowska, M., Samborowska, E., Żeber‐Lubecka, N., Kulecka, M., & Klupa, T. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1332406 · Cited by 5
Nan, S., Li, J., Kuang, Y. K., Feng, J., Wang, H., Niu, J., Wu, Y., Zhang, W., & Nie, C. (2024) · Microorganisms · doi:10.3390/microorganisms12030486 · Cited by 6
“Brown et al. [42] explained that butyrate-producing bacteria, such as Subdoligranulum and Butyricimonas , enhanced epithelial barrier integrity by butyric acid-induced mucin synthesis and increased the expression of tight junction proteins [43].”
BackgroundManipulation and Assessment of Gut Microbiome for Metabolic Studies
Satoor, S. N., Patil, D. P., Kristensen, H. D., Joglekar, M. V., Shouche, Y. S., & Hardikar, A. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1215-5_26 · Cited by 4
Zhao, Y., Alard, P., & Kosiewicz, M. M. (2019) · Journal of Immunology Research · doi:10.1155/2019/8785263 · Cited by 4
Study of the gut microbiome in Egyptian patients with type 1 diabetes mellitus
Al-Lakany, A., Elbanna, A., Rohoma, K. H., Ahmed, S. M., Ibrahim, A. E., Fawzy, M. A., & Header, D. (2023) · Gastroenterology Review · doi:10.5114/pg.2023.126055 · Cited by 5
“In contrast to the present study, Brown et al. (2011) stated that Veillonella can compete for lactate substrate with the butyrate producers and are in statistically higher abundance in cases Gastroenterology Review 2023; 18 (2) than in controls [22].”
BackgroundResultInfluentialInflammatory Pathways Linked to Beta Cell Demise in Diabetes
Imai, Y., Morris, M. A., Dobrian, A. D., Taylor, D., & Nadler, J. L. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_30-2 · Cited by 6
“Several studies have shown that T1D patients exhibit skewed gut microbiota as compared to controls (Brown et al. 2011; Giongo et al. 2011).”
BackgroundMicrobiota: In Health and in Sickness, From Birth to Death
Kuk, S., Uyar, Y., Karaca, S., & Yazar, S. (2016) · Turkish Journal of Parasitology · doi:10.5152/tpd.2016.4789 · Cited by 6
Bucheli, J. E. V., Todorov, S. D., & Holzapfel, W. H. (2022) · Beneficial Microbes · doi:10.3920/bm2022.0022 · Cited by 6
Community and genomic analysis of the human small intestine microbiota
van den Bogert, B. (2013) · doi:10.18174/274416 · Cited by 7
Development of an In Vitro Fermentation Model to Culture the Human Distal Gut Microbiota
McDonald, J. A. K. (2013) · The Atrium (University of Guelph) · Cited by 8
Turpin, P. L., Ahrens, A. P., Russell, J. T., Kindgren, E., Berryman, M. A., Ilonen, J., Atkinson, M. A., Schatz, D., Triplett, E. W., & Ludvigsson, J. (2021) · medRxiv · doi:10.1101/2021.06.07.21258510 · Cited by 4
Self-citationRecent advances in systemic lupus erythematosus and microbiota: from bench to bedside
Zhan, Y., Liu, Q., Zhang, B., Huang, X., & Lu, Q. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0957-7 · Cited by 3
“The decrease in Firmicutes was also observed in autoimmune diseases, such as type I diabetes (T1DM) [26,27] and rheumatoid arthritis [28].”
BackgroundRecent advances and clinical relevance of microbiome dynamics in health and disease
Gavanji, S., Suhail, M., Bencúrová, E., Dandekar, T., & Othman, E. M. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2679197 · Cited by 4
Chapter 10 The intestinal microbiota and allergic and auto-immune disorders in children
de Meij, T. G. J. (2017) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-839-1_10 · Cited by 4
Adar, A., Shalitin, S., Eyal, O., Loewenthal, N., Pinhas‐Hamiel, O., Zuckerman‐Levin, N., Dally-Gottfried, O., Landau, Z., Zung, A., Levy‐Khademi, F., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3318 · Cited by 3
Metagenomics of Toenail Onychomycosis in Three Victorian Regions of Australia
Hainsworth, S., Lawrie, A. C., Vanniasinkam, T., & Grando, D. (2022) · Journal of Fungi · doi:10.3390/jof8111198 · Cited by 3
Prapa, I., Yanni, A. E., Kompoura, V., Mitropoulou, G., Panas, P., Kostomitsopoulos, N. G., & Kourkoutas, Y. (2024) · Nutrients · doi:10.3390/nu16234221 · Cited by 4
I-Cubed (Infection, Immunity, and Inflammation) and the Human Microbiome
Younger, D. S. (2016) · Neurologic Clinics · doi:10.1016/j.ncl.2016.05.006 · Cited by 4
Nandhini, L. P., Kamalanathan, S., & Sahoo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_6 · Cited by 10
Ashwath, P., Premanath, R., Sannejal, A. D., Tammisetti, V. N., Gupta, S. K., & Alla, D. R. (2021) · Springer eBooks · doi:10.1007/978-981-16-5195-3_20 · Cited by 3
Kostoglod, T. V. K., Сергеевна, К. Т., & Livzan, M. A. (2021) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2021-17-4-82-88 · Cited by 3
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1515-8766 · Cited by 3
Gut microbiota and COVID-19: An intriguing pediatric perspective
Valentino, M. S., Esposito, C., Colosimo, S., Caprio, A. M., Puzone, S., Guarino, S., Marzuillo, P., del Giudice, E. M., & Sessa, A. D. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i23.8076 · Cited by 3
The role of probiotics in the management of cardiovascular disease risk factors
Ghanavati, M., Hosseini, S. A., Alipour, M., Ashtary‐Larky, D., & Cheraghpour, K. (2015) · Clinical Excellence · Cited by 3
Harms, R. Z., Ostlund, K. R., Cabrera, M. S., Edwards, E., Smith, V. B., Smith, L. M., & Sarvetnick, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.604157 · Cited by 4
Advances in Probiotics for Health and Nutrition
Zambare, V., Din, M. F. M., Gupta, P., & Prajapati, B. G. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.104299 · Cited by 6
Microbiota-immune crosstalk in autoimmune disorders: Molecular insights and therapeutic pathways
Somasundaram, A., Abdulbari, N., Suja Pandian., R., Pandian, A., Fredrick Raja, E., Saratha., V., Saminathan, U., & Ramasamy, P. (2026) · Comparative Immunology Reports · doi:10.1016/j.cirep.2026.200270 · Cited by 5
“T1D is a chronic autoimmune condition that targets islet cell autoantigens, leading to a significant depletion of pancreatic cells [104].”
Ansari, M. M., Min, Y., Ko, E., Kwon, D., Khan, R., & Son, Y. (2026) · Advanced NanoBiomed Research · doi:10.1002/anbr.202500233 · Cited by 2
Gut Microbiota and Autoimmune Diseases: The Therapeutic Potential of Probiotics
Domagała, A., & Kiecka, A. (2026) · Current Microbiology · doi:10.1007/s00284-026-04992-1 · Cited by 2
Virome and Microbiome Interaction and Their Implication in the Human Gut Health
AboNahas, H. H., El‐Maradny, Y. A., Gezaf, S. A., Nouh, F. A. A., AboNahas, Y. H., Landa‐Acuña, D., Gil-Polo, A., Saied, E. M., & Abdel-Azeem, A. M. (2022) · Springer eBooks · doi:10.1007/978-981-16-1626-6_4 · Cited by 2
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1908-0685 · Cited by 2
Maternal provisions in type 1 diabetes: Evidence for both protective & pathogenic potential
Strachan, E. R., Clemente‐Casares, X., & Tsai, S. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146082 · Cited by 3
“Notably, a decreased abundance of SCFA-producing bacteria has been reported in children at various stages of T1D progression (29, 66, 69, 70, 73) and a decline in gut barrier function, as evidenced by increased permeability and microbial translocation, has been observed in patients (66, 74–77).”
BackgroundKwain, S., Dominy, B. N., Whitehead, K. J., Miller, B. A., & Whitehead, D. C. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14251 · Cited by 2
Sun, Q.-Y., Wang, X.-Y., Huang, Z.-P., Song, J., Zheng, E.-D., Gong, F., & Huang, X.-W. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i12.1824 · Cited by 2
“Prior research has underscored a decrease in the levels of butyryl-CoA dehydrogenase in patients with diabetes relative to the control group, accompanied by a decrease in butyrate production in the gut microbiota[33].”
Yoshida, N., Yasuda, T., Inagaki, Y., Hasegawa, D., Fukumoto, K., Murakami, T., Hirose, R., Dohi, O., Uchiyama, K., Takagi, T., et al. (2025) · Journal of the Anus Rectum and Colon · doi:10.23922/jarc.2024-068 · Cited by 3
Nutritional Recommendations for People with Type 1 Diabetes Mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2500-0477 · Cited by 2
“Current studies suggest an association between reduced production of short-chain fatty acids, especially butyrate, by the microbiome, and an increased risk of T1Dm [126, 132, 133].”
Pathogenesis of Type 1 Diabetes
Pugliese, A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_7 · Cited by 3
Gastrointestinal Tract: Microflora and Transit Aspects
Gomes, A., Pintado, M., & Silva, J. S. E. (2014) · Pan Stanford Publishing eBooks · doi:10.1201/b15676-3 · Cited by 3
Relationship between gut microbiome and diabetes
Annapure, U. S., & Bagul, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00013-1 · Cited by 2
expam—high-resolution analysis of metagenomes using distance trees
Solari, S. M., Young, R. B., Marcelino, V. R., & Forster, S. C. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac591 · Cited by 3
Exposure to Polyphenolic Compounds Modulates Type 1 Diabetes: The Case of Genistein
Huang, G., Xu, J., & Guo, T. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813006-3.00015-5 · Cited by 2
Oka, K., ΜcCartney, Ε., Ariyoshi, T., Kudo, H., Vilà, B., de Jong, L., Kozłowski, K., Jankowski, J., Morgan, S., Kruger, C. L., et al. (2019) · Toxicology Research and Application · doi:10.1177/2397847319826955 · Cited by 2
Diabetes Mellitus’ta Mikrobiyotanın Rolü ve Hedeflenmesi
Aksoyalp, Z. Ş., & Nacıtarhan, C. (2021) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.711605 · Cited by 2
Gómez-Chavarín, M., & Morales-Gómez, M. R. (2017) · Archivos de Neurociencias · doi:10.31157/an.v22i2.153 · Cited by 6
Associations Between Nutrition, Gut Microbial Communities, and Health in Nonhuman Primates
Clayton, J. B. (2015) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 2
Maternal humoral factors modulate offspring gut immune homeostasis to mitigate diabetes developmentPreprint
Strachan, E. R., Pessoa-Soares, L., Ju, T., Schcolnik‐Cabrera, A., Wang, H., Akbari, M., Basso, P. J., Winer, D. A., Huang, C., Julien, O., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.28.604371 · Cited by 2
Bally, P. (2015) · theses.fr (ABES) · doi:10.70675/bf447e7czf5dcz467bz88d6z8edaad84e76a · Cited by 4
The Microbiome as an Endocrine Organ
Masetti, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00118-3 · Cited by 1
Gut microbiota and endometriosis
Yoshino, O., Ono, Y., & Hiraoka, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820661-4.00011-x · Cited by 1
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01040-5 · Cited by 1
“duktion an kurzkettigen Fettsäuren, insbesondere Butyrat, durch das Mikrobiom und einem erhöhten Risiko, an T1Dm zu erkranken, besteht [154, 160, 161].”
Enhancing Type 1 Diabetes Care by Embracing an Integrative Approach
Neville, L. (2023) · Integrative and Complementary Therapies · doi:10.1089/ict.2023.29088.lne · Cited by 1
“21,22 T1D studies using mouse models, such as non-obese diabetic (NOD) mice, have shown that treatment with broad-spectrum antibiotics can alter the composition of gut microbes (in particular, a decrease in Bifidobacterium spp.).”
Zawada, A. E., Skrzypczak-Zielińska, M., Gondek, S., Witkowski, P., Rychter, A. M., Ratajczak, A. E., Karczewski, M., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2024) · Endokrynologia Polska · doi:10.5603/ep.98903 · Cited by 1
Metagenomics-guided reengineering of the gut microbiome
Dhotre, D. P., & Karmarkar, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91631-8.00011-1 · Cited by 2
Magwebu, Z. E., Khoza, S., Mazinu, M., Jordaan, E., Ghai, M., & Chauke, C. G. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-04795-9 · Cited by 1
“The elevated ratio of Firmicutes-to-Bacteroidetes (F/B) is observed in hypertensive individuals [6, 7], and can also be potentially used as a biomarker for other metabolic syndromes such as obesity, and diabetes mellitus [8–11].”
Does schistosome infection affect behavior through the gut-brain axis?
Combrink, L., Spaan, J. M., Perret, A., Maehara, T., Hyun, B., Parker, D., Johns, J. L., Blouin, M. S., Magnusson, K. R., & Steinauer, M. L. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013088 · Cited by 1
“Alistipes have also been found to be protective against liver disease [79,80] and colitis [81].”
Zhan, J.-Y., Wang, W.-R., Zhan, T., Yang, J., Liang, Y., Yu, R.-H., & Wang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1730351 · Cited by 2
“Some researchers have identi fi ed common changes in gut fl ora in SSc. Concretely, the bene fi cial commensal genera decreased, including FP (226, 227), Clostridiaceae , Rikenella , Bacteroides , Prevotella , Roseburia , Pseudobutyrivibrio , Escherichia/Shigella , and Raecalibacterium (228), whereas the pathobiont gener…”
InfluentialAllergic and Immunologic Disorders
Szajewska, H., & Nowak-Wegrzyn, A. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00032-x · Cited by 3
Ardissone, A. N., Kemppainen, K. M., & Triplett, E. W. (2017) · Diabetes Case Reports · doi:10.4172/2572-5629.1000128 · Cited by 1
“Brown [29] 4 months - 3 years 8 Turku, Finland IA Illumina GAIIx; WGS NA Not reported Decrease in butyrate producing bacteria and mucin degrading bacteria in cases No, but cases and controls were matched for age and HLA genotype”
BackgroundResultSelf-citationThe role of gut microbiota in the development of type 1 diabetes
Xie, X. W., & Yue-xin, D. (2018) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2018.09.00304 · Cited by 1
Nanobased scientific and technological solutions for the management of diabetes mellitus
Picu, A. A., Petcu, L. M., & Chifiriuc, M. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816506-5.00014-0 · Cited by 1
Microbioma y enfermedades crónicas
Khouri, L. S., Flores-Andrade, X. A., González, R. S. M., Olmos, I. O. V., Velez-Pintado, M., & Durán, J. P. G. (2022) · Anales Médicos de la Asociación Médica del Centro Médico ABC · doi:10.35366/108781 · Cited by 1
The Future Perspective of Gut Microbiota and Autoimmune Thyroid Disease
Sihombing, A. E. N., & Prajitno, J. H. (2022) · International Journal of Research Publications · doi:10.47119/ijrp1001161120234384 · Cited by 1
Rajeev, A., & Chattopadhyay, I. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_13 · Cited by 1
Wang, X. R., Zhao, T., Zhang, J., & Xu, H. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105442 · Cited by 1
Koshida, T., Gohda, T., Kaga, N., Taka, H., Shimozawa, K., Murakoshi, M., Yamashiro, Y., & Suzuki, Y. (2024) · Nutrition · doi:10.1016/j.nut.2024.112633 · Cited by 1
Jiang, Y., Yang, X., Lei, Y., Li, S., Chen, X., & Jiang, L. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1619287 · Cited by 3
Speculation on Prevention of Type 1 Diabetes
Insel, R. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4051-2_31 · Cited by 1
Microbe-based approaches for the treatment of diabetes
Knip, M., & Siljander, H. (2015) · Diabetes Management · doi:10.2217/dmt.15.1 · Cited by 1
Self-citationBrief commentary for brain, behavior, and immunity
Auvinen, P. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.003 · Cited by 1
“For a very long time, microbes have been claimed to have an important role in human health (e.g., Turnbaugh et al., 2007; Brown et al., 2011; Abt and Artis, 2009).”
BackgroundThe Human Microbiome and I-Cubed: A Modern Medical Paradigm
Younger, D. S. (2016) · World Journal of Neuroscience · doi:10.4236/wjns.2016.64031 · Cited by 1
Prevention of Autoimmune Disease
Harrison, L. C., & Wentworth, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00079-4 · Cited by 1
Contrasting Efforts: The Microbiome and Type 1 Diabetes
Russell, J. T., & Triplett, E. W. (2017) · Diabetes Case Reports · doi:10.4172/2572-5629.1000129 · Cited by 1
Self-citationPathogenesis of Type 1 Diabetes
Pugliese, A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_7-1 · Cited by 1
The Intricate Relationship between Diabetes, Diet and the Gut Microbiota
Pîrcălăbioru, G. G., Picu, A. A., Petcu, L. M., Popa, M., & Chifiriuc, M. C. (2018) · InTech eBooks · doi:10.5772/intechopen.70602 · Cited by 1
“Children from Mexico, Pathophysiology - Altered Physiological States72 Indonesia, Thailand and Malawi have a diet with a low level of animal protein and fat and a high content of plant polysaccharides and fibre, which translate into a microbiota rich in Prevotella.”
BackgroundInfluentialNutritional Recommendations for People with Type 1 Diabetes Mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1284-6036 · Cited by 2
Mycobacteria, Immunoregulation, and Autoimmunity
Rook, G. A. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814603-3.00009-4 · Cited by 2
Nutritional Recommendations for People with Type 1 Diabetes Mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1946-3753 · Cited by 2
“Current studies also suggest an association between reduced production of short-chain fatty acids, especially butyrate, by the microbiome, and an increased risk of type 1 diabetes [118, 124, 125].”
BackgroundSystems Biology of the Gut Microbiome in Metabolic Diseases
Karlsson, F. H. (2014) · Chalmers Publication Library (Chalmers University of Technology) · Cited by 4
Reply to letter to the editor by Assoc. Prof. Yusuf Ozgur Cakmak, MD, PhD
Scheperjans, F. (2015) · Movement Disorders · doi:10.1002/mds.26259 · Cited by 1
“Some studies suggested impaired barrier function with lower Prevotella abundance related to, for example, type 1 diabetes.(5,6) In contrast, others have reported higher Prevotella abundance associated with”
BackgroundHall, L. J. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734278907.793574624 · Cited by 1
Mycobacteria, Immunoregulation, and Autoimmunity
Rook, G. A. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-799964-7.00001-6 · Cited by 1
Towards the Identification of Condition‐Specific Microbial Populations from Human Metagenomic Data
Laczny, C. C., & Wilmes, P. (2014) · Wiley eBooks · doi:10.1002/9783527672165.ch11
[Metagenomics in studying gastrointestinal tract microorganism].
Xu, B., Yang, Y., Li, J., Tang, X., Mu, Y., & Huang, Z. (2013) · PubMed
Pratesi, R. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.08.t.19527
A Powerful Correlation Method for Microbial Co-Occurrence Networks
Ziebell, S. E. (2015) · UA Campus Repository (The University of Arizona)
Gastrointesnal Tract: Microflora and Transit Aspects
Silva, J. P. S. E., & Freitas, A. C. (2014) · doi:10.1201/b15676-5
Bach, J., & Pérez, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00025-3
Cox, A. J., West, N. P., & Cripps, A. W. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch17 · Cited by 1
The Impact of Microbiome Alterations in the NOD Mouse Model of Type 1 Diabetes
Yau, L., & Yick, C. (2014) · TSpace (University of Toronto)
Genetic subtypes in unicellular intestinal parasites with special focus on Blastocystis
Forsell, J. (2017) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Metadata
- Authors
- Brown, C. T., Davis-Richardson, A. G., Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A., & Triplett, E. W.
- Affiliations
- University of Florida (US)
- University of Eastern Finland (FI)
- University of Helsinki (FI)
- Tampere University Hospital (FI)
- University of Oulu (FI)
- Turku University Hospital (FI)
- Corresponding author
- Triplett, Eric W.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e25792
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3197175
- OpenAlex
- W2060915038
- Cited by
- 778
- References
- 48
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 53 · 2023: 60 · 2022: 69 · 2021: 73 · 2020: 66 · 2019: 69 · 2018: 68 · 2017: 59 · 2016: 55 · 2015: 49 · 2014: 47 · 2013: 38 · 2012: 22
- FWCI
- 14.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- type 1 diabetes, gut microbiota, autoimmunity, autoantibodies, metagenomics, bacterial gene function, carbohydrate metabolism, bacterial adhesion, flagella synthesis, butyrate production, short-chain fatty acids, mucin degradation, intestinal barrier integrity, lactate-utilizing bacteria, 16S rRNA
- MeSH terms
- Autoantibodies, Butyrates, Diabetes Mellitus, Type 1, Fatty Acids, Volatile, Humans, Mucins, RNA, Ribosomal, 16S, Autoimmunity, Case-Control Studies, Databases, Nucleic Acid, Gastrointestinal Tract, Metagenome, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.